<TEXT>&#2;<DATELINE>2020-06-30</DATELINE><TITLE>3CLpro inhibitors as a potential therapeutic option for COVID-19: Available evidence and ongoing clinical trials</TITLE><BODY>&#3;</BODY></TEXT>